CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
truSculpt RFdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03285581
NCT03285581N/ACompleted

Open-label, Prospective, Multicenter Pivotal Study of the Cutera truSculpt™ Radiofrequency Device for Wrinkle Reduction

Cutera Inc.·interventional·Posted Sep 18, 2017·Updated Sep 13, 2023

In Brief

A clinical study evaluating truSculpt RF for Wrinkle Reduction. Completed, enrolled 39 participants across 2 sites.

Detailed Summary

The purpose of this pivotal investigation is to evaluate the safety and efficacy of the Cutera truSculpt™ radiofrequency (RF) Device for Wrinkle Reduction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 18, 2017
Enrollment StartAug 15, 2017
Primary CompletionDec 20, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.8 years ago

Interventions

truSculpt RFdevice

Subjects will receive RF treatments